NextCure Inc reports results for the quarter ended in September - Earnings Summary

NextCure

05/11/2021 20:16

* NextCure Inc  NXTC.OQ  reported a quarterly adjusted loss
of 65 cents​​ per share for the quarter ended in September. The
mean expectation of nine analysts for the quarter was for a loss
of 67 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* NextCure Inc's reported EPS for the quarter was a loss of 65
cents​.
* The mean earnings estimate of analysts had fallen by
about 2.5% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* NextCure Inc shares had risen by 29.4% this quarter and
lost 20.0% so far this year.
* The company reported a quarterly loss of $17.93 million.
* Wall Street's median 12-month price target for NextCure Inc is
$16.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 
This summary was machine generated November 5 at 08:16 p.m.
 ​All figures in US dollars unless otherwise stated